Fingerprint
Dive into the research topics of 'Micellar Formulation of Talazoparib and Buparlisib for Enhanced DNA Damage in Breast Cancer Chemoradiotherapy'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Micellar Formulation of Talazoparib and Buparlisib for Enhanced DNA Damage in Breast Cancer Chemoradiotherapy
Allison N. Duross, Megan J. Neufeld, Madeleine R. Landry, Justin G. Rosch, Colin T. Eaton, Gaurav Sahay, Charles R. Thomas, Conroy Sun
Research output: Contribution to journal › Article › peer-review
18
Scopus
citations